EverydayHealthLogo
Dr. Billy Loo, MD, PHD

Dr. Billy Loo, MD, PHD

Palo Alto, CA

19 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Loo, Radiation Oncologist in Palo Alto, CA?

    Dr. Billy Loo, MD, PHD is a Radiation Oncologist, who primarily practices in Palo Alto, CA with 1 additional practice location. He has been practicing for over 19 years and is board certified. Dr. Loo completed his residency at Stanford University Medical Center. Dr. Loo is fluent in English, and is currently seeing new patients. Dr. Loo’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Loo’s office at (650) 736-7143.

    What are Areas of Expertise for Dr. Loo?

    Dr. Billy Loo, MD, PHD is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Loo empowers patients to confidently navigate their health journey, specializing in Lung Cancer, Stereotactic Radiosurgery, Thoracic Cancers, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Loo is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Loo go to medical school and complete their residency?

    • Residency: Stanford University Medical Center

    Is Dr. Loo board certified as a Radiation Oncologist?

    Yes, Dr. Billy Loo, MD, PHD is board certified by the American Board of Radiology since 2006

    What languages does Dr. Loo speak?

    Dr. Loo and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does a Radiation Oncologist like Dr. Loo typically treat?

    As a Radiation Oncologist, Dr. Loo diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Loo. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.

    Also known as:

    • Lung Cancer
    • Right upper lobe lung cancer
    • Bronchial cancer
    • Malignant neoplasm of lung
    • Right lung cancer
    • Left Lung Cancer
    • Upper Lobe Lung Cancer
    • Bronchial Cancer

    ICD-10 Codes:

    • C3411: Malignant neoplasm of upper lobe, right bronchus or lung
    • C3491: Malignant neoplasm of unspecified part of right bronchus or lung
    • C3412: Malignant neoplasm of upper lobe, left bronchus or lung

    Also known as:

    • History of Radiation Therapy
    • Radiation Therapy
    • Past Radiation Treatment
    • Previous Radiotherapy
    • History of Radiotherapy

    ICD-10 Codes:

    • Z923: Personal history of irradiation

    What procedures does a Radiation Oncologist like Dr. Loo typically perform?

    As a Radiation Oncologist, procedures performed by Dr. Billy Loo may include:

    Please contact Dr. Loo's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Loo accept my insurance?

    Dr. Loo accepts most major insurance plans. Important: Please call our office at (650) 736-7143 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Loo accept in Palo Alto, CA?

    Dr. Loo in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Advantage

    • All Other Third Party

    • Cigna Group

    • CVS Health (formerly Aetna)

    • Federal government of the United States

    • Medicaid

    • Medicare

    • State of California

    • UMR Administered Payer

    • UnitedHealth Group

    View All Insurances

    Where is Dr. Loo's office located?

    Stanford Radiation Oncology

    875 Blake Wilbur Dr

    Palo Alto, CA 94304

    (650) 736-7143

    Get Directions

    Dr. Billy Loo's Practice 2

    300 Pasteur Dr

    Stanford, CA 94305

    Get Directions

    Recognitions

    Publications

    Feasibility and potential utility of multicomponent exhaled breath alysis for predicting

    , 2014

    An ultrasensitive method for quantitating circulating tumor D with broad patient coverage.

    , 2014

    A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non

    , 2014

    Investigating the Feasibility of Rapid MRI for Image

    Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor

    , 2013

    Radiotherapy for nodenoid cystic carcinomas of major salivary glands.

    , 2013

    An Observatiol Study of Circulating Tumor Cells

    , 2013

    Non-small cell lung cancer, version 2.2013.

    , 2013

    Thymomas and Thymic Carcinomas Clinical Practice Guidelines in Oncology

    , 2013

    Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.

    , 2013

    Metabolic Tumor Volume Predicts Disease Progression

    , 2013

    Small Cell Lung Cancer

    , 2013

    The Optimal Use of Radiotherapy in Small Cell Lung Cancer

    , 2013

    Reproducibility of Four-dimensiol Computed Tomography-based Lung Ventilation Imaging

    , 2012

    Non-Small Cell Lung Cancer

    , 2012

    Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors

    , 2012

    Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors

    , 2012

    Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes

    , 2012

    Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images

    , 2012

    Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer

    , 2012

    The Magement of Patients With Stage IIIA Non

    , 2012

    An automated method for comparing motion artifacts in cine four

    , 2012

    Malignt Pleural Mesothelioma

    , 2012

    ON-BOARD IMAGING VALIDATION OF OPTICALLY GUIDED STEREOTACTIC RADIOSURGERY POSITIONING SYSTEM FOR

    , 2011

    Molecular Imaging with C-11-PD153035 PET

    , 2011

    Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?

    , 2011

    HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL

    , 2011

    IN REGARD TO BROWN ET AL. (INT J RADIAT ONCOL BIOL PHYS 2010;78:323-327) REPLY

    , 2011

    INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA

    , 2011

    POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER

    , 2011

    Tumor Volume as a Potential Imaging-Based Risk

    , 2011

    Reducing 4D CT artifacts using optimized sorting based on atomic similarity

    , 2011

    Investigation of four-dimensiol computed tomography

    , 2011

    HYPOFRACTIOTION RESULTS IN REDUCED TUMOR CELL KILL COMPARED TO CONVENTIOL FRACTIOTION FOR TUMORS

    , 2011

    Four-dimensiol computed tomography pulmory ventilation images vary with deformable image

    , 2011

    Stereotactic ablative radiotherapy: what's in a me?

    , 2011

    Motion Magement and Image Guidance for Thoracic Tumor Radiotherapy: Clinical Treatment Programs

    , 2011

    INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX

    , 2011

    STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER

    , 2010

    Altertives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?

    , 2010

    INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER

    , 2010

    Marked Tumor Response

    , 2009

    Cooperative Group Research Efforts in Thoracic Maligncies 2009

    , 2009

    METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER

    , 2009

    Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy

    , 2009

    RETROSPECTIVE ALYSIS OF ARTIFACTS IN FOUR

    , 2008

    Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy

    , 2008

    Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

    , 2008

    Quantification of motion of different thoracic locations using four-dimensiol computed tomography

    , 2007

    Metabolic tumor burden predicts for disease progression and death in lung cancer

    , 2007

    Clinical role of F-18-FDG PET/CT

    , 2007

    Results of a phase I dose-escalation study using single

    , 2006

    Indirect MR lymphangiography of the head and neck using conventiol gadolinium contrast

    , 2006

    Four-dimensiol cone-beam computed tomography using an on-board imager

    , 2006

    Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report

    , 2003

    A new sample preparation method for biological soft X-ray microscopy

    , 2001

    Automatic image acquisition, calibration and montage assembly for biological X-ray microscopy

    , 2000

    X-RAY STEREOMICROSCOPY

    , 1992

    Feasibility and potential utility of multicomponent exhaled breath analysis for predicting

    , 2014

    The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy

    , 2014

    An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

    , 2014

    A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non

    , 2014

    PET Imaging of Stroke-Induced Neuroinflammation in Mice Using [F-18]PBR06

    , 2014

    The Relationship Between Serial [

    Imaging Features Associated With Dise

    Investigating the Feasibility of Rapid MRI for Image

    Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor

    , 2013

    4D CT lung ventilation images are affected by the 4D CT sorting method

    , 2013

    Clinical impact of dose overestimation by effective path length calculation

    , 2013

    Radiotherapy for nonadenoid cystic carcinomas of major salivary glands.

    , 2013

    Toward a planning scheme for emission guided radiation therapy (EGRT)

    , 2013

    An Observational Study of Circulating Tumor Cells

    , 2013

    Non-small cell lung cancer, version 2.2013.

    , 2013

    Thymomas and Thymic Carcinomas Clinical Practice Guidelines in Oncology

    , 2013

    Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.

    , 2013

    Metabolic Tumor Volume Predicts Disease Progression

    , 2013

    Small Cell Lung Cancer

    , 2013

    The Optimal Use of Radiotherapy in Small Cell Lung Cancer

    , 2013

    American College of Chest Physicians

    , 2012

    Metabolic imaging metrics correlate with survival

    , 2012

    Reproducibility of Four-dimensional Computed Tomography-based Lung Ventilation Imaging

    , 2012

    Non-Small Cell Lung Cancer

    , 2012

    Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response

    , 2012

    Esophageal tolerance to high-dose stereotactic ablative radiotherapy

    , 2012

    Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors

    , 2012

    Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors

    , 2012

    Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes

    , 2012

    Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images

    , 2012

    Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer

    , 2012

    The Management of Patients With Stage IIIA Non

    , 2012

    Interim-treatment quantitative PET parameters predict progression

    , 2012

    Evaluation of a metal artifact reduction technique in tonsillar cancer delineation.

    , 2012

    An automated method for comparing motion artifacts in cine four

    , 2012

    Malignant Pleural Mesothelioma

    , 2012

    Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non

    , 2012

    Correlation between metabolic tumor volume

    , 2011

    ON-BOARD IMAGING VALIDATION OF OPTICALLY GUIDED STEREOTACTIC RADIOSURGERY POSITIONING SYSTEM FOR

    , 2011

    What the Diagnostic Radiologist Needs to Know about Radiation Oncology

    , 2011

    Molecular Imaging with C-11-PD153035 PET

    , 2011

    Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?

    , 2011

    Results from a Single Institution Ph

    , 2011

    HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL

    , 2011

    IN REGARD TO BROWN ET AL. (INT J RADIAT ONCOL BIOL PHYS 2010;78:323-327) REPLY

    , 2011

    INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA

    , 2011

    POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER

    , 2011

    Tumor Volume as a Potential Imaging-Based Risk

    , 2011

    Reducing 4D CT artifacts using optimized sorting based on anatomic similarity

    , 2011

    Investigation of four-dimensional computed tomography

    , 2011

    HYPOFRACTIONATION RESULTS IN REDUCED TUMOR CELL KILL COMPARED TO CONVENTIONAL FRACTIONATION FOR

    , 2011

    Four-dimensional computed tomography pulmonary ventilation images vary with deformable image

    , 2011

    Stereotactic ablative radiotherapy: what's in a name?

    , 2011

    Motion Management and Image Guidance for Thoracic Tumor Radiotherapy: Clinical Treatment Programs

    , 2011

    INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX

    , 2011

    CyberKnife Stereotactic Ablative Radiotherapy for Lung Tumors

    , 2010

    STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER

    , 2010

    Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?

    , 2010

    Stereotactic body radiation therapy

    , 2010

    INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER

    , 2010

    Marked Tumor Response

    , 2009

    Re: The safety and efficacy of robotic image-guided radiosurgery system treatment for intra

    , 2009

    Cooperative Group Research Efforts in Thoracic Malignancies 2009

    , 2009

    METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER

    , 2009

    Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy

    , 2009

    Stereotactic body radiotherapy for primary and oligometastatic cancers

    , 2009

    Post-Operative Radiation Therapy (PORT) in Completely Resected Non-Small-Cell Lung Cancer

    , 2008

    RETROSPECTIVE ANALYSIS OF ARTIFACTS IN FOUR

    , 2008

    Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy

    , 2008

    Complications of ablative therapies in lung cancer

    , 2008

    Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

    , 2008

    Quantification of motion of different thoracic locations using four-dimensional computed tomography

    , 2007

    Metabolic tumor burden predicts for disease progression and death in lung cancer

    , 2007

    RT_Image: An open-source tool for investigating PET in radiation oncology

    , 2007

    Impact of integrated PET/CT on variability of target volume delineation in rectal cancer

    , 2007

    Clinical role of F-18-FDG PET

    , 2007

    Results of a phase I dose-escalation study using single

    , 2006

    Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast

    , 2006

    Four-dimensional cone-beam computed tomography using an on-board imager

    , 2006

    Optical detection of tumors in vivo by visible light tissue oximetry

    , 2005

    Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report

    , 2003

    A new sample preparation method for biological soft X-ray microscopy

    , 2001

    Automatic image acquisition, calibration and montage assembly for biological X-ray microscopy

    , 2000

    X-RAY STEREOMICROSCOPY

    , 1992

    An environmental sample chamber for x-ray microscopy

    , 1992

    What is Dr. Loo's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Loo's National Provider Identifier (NPI) number is 1720167711.

    What common questions do patients ask about Dr. Loo?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Loo

    What is Dr. Billy Loo's specialty?

    Dr. Loo is a Radiation Oncologist near Palo Alto, CA.

    What does a Radiation Oncologist do?

    A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors.

    Is this Dr. Billy Loo affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Loo is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Radiation Oncologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Radiation Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Billy Loo accepting new patients in Palo Alto, CA?

    Yes, Dr. Billy Loo is accepting new patients at this time.

    Does Dr. Billy Loo offer online booking?

    Please contact Dr. Loo's office at (650) 736-7143 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Billy Loo?

    Please contact Dr. Loo's office at (650) 736-7143 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Billy Loo have?

    Dr. Billy Loo is certified by the American Board of Radiology.

    Other Radiation Oncologist Near Palo Alto, CA

    WM

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Santa Clara, CA
    SB

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    Dr. Beth Beadle, MD

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists